List view / Grid view
Environment plays a significant role in the way businesses ideate, communicate and create. While the global population is more connected than ever, there’s a certain level of collaboration that can only be achieved with proximity. To that end, 3M Drug Delivery Systems' (DDS) UK organisation is bringing its teams under…
A study from the VA Puget Sound Healthcare System has found a link between the use of benzodiazepines and suicide in patients with COPD or PTSD...
"Previous studies have found an alarming rise in ACOS in women in recent years and that the mortality rate from ACOS was higher in women," said Prof To...
A study suggests long-term inhaled corticosteroids (ICS) in patients with COPD may increase the risk of bone fractures in both men and women...
Researchers have discovered that genetic variations in the anatomy of the lungs could serve as indicators to help identify people who are particularly at risk for COPD...
AstraZeneca has announced positive top-line results of the Phase IV ASCENT trial for Tudorza Pressair in patients with moderate to very severe COPD...
Novartis has announced positive results from the FLASH study examining the safety and efficacy of directly switching COPD patients from Seretide to Ultibro Breezhaler...
Older people who use steroid inhalers are more likely to suffer particular bacterial infections...
The FDA has accepted Sandoz’s New Drug Application for fluticasone propionate / salmeterol combination product, a generic version of Advair Diskus...
22 December 2016 | By Niamh Louise Marriott, Digital Editor
Based on the results Orion is planning to apply for a marketing authorisation for the product in Europe. Orion currently estimates that the marketing...
3 October 2016 | By Peter Brady, CEO Orbital Media and Dr Martin Goldman, independent medical officer, Iatros Consulting
Dr Martin Goldman joins Peter Brady, Orbital Media's CEO, to discuss how to untap the potential of social media sourced real world evidence...
20 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Cachexia is a condition of involuntary weight loss, undernourishment and a number of negative side-effects that can be seen in patients with Chronic obstructive pulmonary disease (COPD), as well as in cancer and in several severe inflammatory diseases, such as AIDS, congestive heart failure, tuberculosis and rheumatoid arthritis...
20 June 2016 | By Victoria White, Digital Content Producer
Verona Pharma has successfully secured funding commitments to raise gross proceeds of £44.7m through a conditional placing with new and existing investors...
10 May 2016 | By Victoria White, Digital Content Producer
RPL554 is a novel inhaled dual PDE3/PDE4 inhibitor with both bronchodilator and anti-inflammatory properties in the same molecule...
8 April 2016 | By Victoria White, Digital Content Producer
A new study shows that levels of eosinophils can help identify patients with COPD who may and may not benefit from the addition of ICS treatment...
